MMA
IBB icon

Miracle Mile Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Miracle Mile Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Buy
11,166
+5
+0% +$859 0.02% 313
2026
Q1 		$1.88M Sell
11,161
-1,856
-14% -$317K 0.03% 311
2025
Q4 		$2.2M Buy
13,017
+521
+4% +$84.6K 0.03% 291
2025
Q3 		$1.8M Sell
12,496
-709
-5% -$96.8K 0.03% 311
2025
Q2 		$1.67M Sell
13,205
-1,642
-11% -$202K 0.03% 273
2025
Q1 		$1.9M Sell
14,847
-6,628
-31% -$899K 0.04% 223
2024
Q4 		$2.84M Buy
21,475
+4,782
+29% +$672K 0.06% 181
2024
Q3 		$2.43M Sell
16,693
-964
-5% -$139K 0.06% 169
2024
Q2 		$2.42M Sell
17,657
-7,197
-29% -$961K 0.06% 168
2024
Q1 		$3.41M Buy
24,854
+308
+1% +$42.1K 0.09% 143
2023
Q4 		$3.33M Sell
24,546
-300,787
-92% -$36.7M 0.09% 133
2023
Q3 		$39.8M Buy
325,333
+1,399
+0.4% +$178K 1.23% 25
2023
Q2 		$41.1M Buy
323,934
+20,653
+7% +$2.68M 1.25% 24
2023
Q1 		$39.2M Buy
303,281
+12,095
+4% +$1.58M 1.27% 18
2022
Q4 		$38.2M Buy
291,186
+257,089
+754% +$33.2M 1.31% 19
2022
Q3 		$3.99M Buy
34,097
+7,790
+30% +$967K 0.19% 81
2022
Q2 		$3.1M Buy
26,307
+17,572
+201% +$2.09M 0.15% 116
2022
Q1 		$1.14M Buy
+8,735
New +$1.14M 0.05% 220
2020
Q3 		– Sell
-1,610
Closed -$220K – 375
2020
Q2 		$220K Buy
+1,610
New +$205K 0.02% 284
2019
Q2 		– Sell
-1,790
Closed -$200K – 272
2019
Q1 		$200K Buy
+1,790
New +$196K 0.02% 252

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Miracle Mile Advisors's IBB Position: Q2 2026 in Review

Miracle Mile Advisors increased its iShares Biotechnology ETF (IBB) stake by 0.04% in Q2 2026, buying an estimated $859 and bringing the position to 11,166 shares worth $2.12M. The position accounts for 0.02% of the portfolio, ranked #313.

Miracle Mile Advisors first reported a position in IBB in Q1 2019 and has held it in 20 quarters since. The position peaked at $41.1M in Q2 2023. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Miracle Mile Advisors held 11,166 shares of iShares Biotechnology ETF worth $2.12M as of Q2 2026.
  • Miracle Mile Advisors bought 5 iShares Biotechnology ETF shares in Q2 2026, an estimated $859.
  • iShares Biotechnology ETF made up 0.02% of Miracle Mile Advisors's portfolio in Q2 2026, its #313 holding.
  • Miracle Mile Advisors first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 20 quarters since.
  • Miracle Mile Advisors's iShares Biotechnology ETF position peaked at $41.1M in Q2 2023.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.